The development of colonic stenosis is a rare complication of Crohn's disease (CD) without a postsurgical anastomose history. The management and long term follow-up results of colonic stricture due to CD have not been clearly defined. In this study, we aimed to characterize de novo colonic stricture due to CD. We evaluated 702 patients with CD to investigate for colonic stricture. Colonic stricture was considered to exist when passage of a standard colonoscope was not possible and diagnosed radiologically and endoscopically in this study. Of the 702, 14 had colonic stricture according to the above definition criteria. Of the 14, 8 were male. Stricture diagnosed date varied from 0 to13 years after the CD was diagnosed. Localization of the strictures differed from rectum to the ceacum. Of the 14, 3 patients had more than 1 stricture. Pathologic examination of the stricture showed no dysplasia or malignancy at the beginning and during the follow-up. De novo colonic stricture due to CD is a rare condition according to the presented study's results. Distribution of the stricture varied from the rectum to ceacum without an increased colonic cancer risk. We observed antifibrotic role of tiopurines and biologics in this study, limitedly.
INTRODUCTION
Intestinal stricture is one of the main causes of hospitalization and cost in patients with Crohn's disease (CD) (Lichtenstein et al., 2009) . It occurs more frequently due to the surgical anastomoses (Cosnes et al., 2005; Louis et al., 2007; Oostenbrug et al., 2006) . Although de novo colonic stenosis is a rare complication of CD (less than 1%), it must be a typical complication by time because of transmural involvement of the bowel wall (Lichtenstein et al., 2009; Cosnes et al., 2005; Louis et al., 2007; Oostenbrug et al., 2006) . It was reported that shortened tubular colon and colonic stricture as strong risk factors for the development of colorectal cancer (CRC) (Farraye et al., 2010) , thus directed biopsies of strictures is always recommended, with people now aware that development of any stricture is an ongoing dynamic pathologic process which includes both fibrotic and antifibrotic components (Strong et al., 2007; Lichtenstein et al., 2006; Vermeire et al., 2007; Van Assche et al., 2004; Hanauer et al., 2002) . Thus, tiopurines and particularly biologics might be good options before giving a surgical desicion. However, there is a concern regarding biologic and their rapid healing effect which may lead to perforation on the effected bowel segment (Vermeire et al., 2007; Van Assche et al., 2004; Hanauer et al., 2002) . In this study, we aimed to characterize de novo colonic stricture due to CD by giving long *Corresponding author. E-mail: metin_basaranoglu@yahoo.com. Tel: +902125540570. Fax: +902125540570. long term follow-up results.
METHODOLOGY
We performed a retrospective study among patients with CD at our inflammatory bowel disease (IBD) Center in Ankara, Turkey. In this center, we have used chart review system since 1995. The study was approved by Ankara Yüksek Ihtisas Hospital Ethics Committee and confidentiality of records was maintained according to the guidelines issued by the health authorities. The diagnosis of CD was established when clinically, endoscopically and radiologically findings were supported by histologic evidences and exclusion of other disorders known to cause intestinal inflammation. Mycobacteria were excluded by tissue staining and cultures because of high incidence of tuberculosis in Turkey. The diagnosis of colonic stricture was performed endoscopically and radiologically. A colonic stricture was considered to exist when passage of a standard colonoscope was not possible. Biopsy and histologic examination of stricture was performed in each patient at the initial diagnosis and during the follow-up term. Date of the CD diagnosed, stricture diagnosed, localization of the stricture (s), number, lenght, and type of the stricture (s), biopsy results, type of the therapy before and after the stricture diagnosed, and response to therapy were all evaluated in each patient. These patients are still being followed at IBD center.
RESULTS
Of the 702 patients with CD, 14 had colonic stricture and 6 were female (Table 1 ). All patients had one or more than one complaints in his or her history such as abdominal pain, diarrhea, weight loss or fever at the presentation. Mean age was 34.5 years. Stricture diagnose date varied from 0 to 13 years after the CD was diagnosed. Two cases presented by colonic stricture at the initial diagnosis. Localization of the strictures was differed from rectum to the ceacum. Of the 14 patients, 3 had more than 1 colonic stricture. Two patients had 3 colonic strictures and 1 had 2 strictures. Pathologic examination of the colonic stricture showed no dysplasia or malignancy during the follow-up. Of the 14 patients, 4 had only colitis without ileum involvement; left colon in 2 cases, one with sigmoid and one with transvers colon involvement. All patients with or without dilation had put on mainly azotiopurine plus oral steroid with mesalazine after the diagnosing of colonic stricture (Table 2) . Therapy results are as follows: 7 patients showed partial response; 4 had complete resolution; and 3 had no response after at least 6 months therapy. One of the nonresponders had 3 colonic strictures as shown in Figures 1 and 2 . He had 9 years history and used azotiopurine plus steroids irregularly. Abdominal tomograpy showed that colonic wall was thickened, particularly in the right colon with 22 and 12 mm in transvers and 9 mm in sigmoid colon.
Small bowel contrast examination showed tickened wall in the distal part of ileum. Double contrast examination of the colon showed 3 long strictures involved in transvers, left and sigmoid colon (Figures 1 and 2) . The lengths of the strictures were 3, 6 and 2 cm, respectively. Colonoscopy showed active colonic mucosal inflammation with obstructive stenosis. Biopsy and histologic examination showed no dysplasia. After the full discussion with the patient and his hesitation to the surgery, biologic therapy (adalimumab: 160 mg sc, then 14 days later: 80 mg sc and 14 days later: 40 mg every 2 weeks sc) was started. An oral steroid therapy was added (40 mg/day prednisolone for 1 month, then gradually decreased for the last 2 months and stopped). His condition was dramatically improved.
Four months later, magnetic resonance imaging enterography was performed and showed significant improvement on the narrowing segments, particularly in the sigmoid and right colon (Figures 3 and 4) . He had no complaints for the last 24 months during the adalimumab therapy. However, colonoscopy performed at the last examination and showed that a narrowing segment in the middle of the left colon and endoscopy failed to pass. Thus, the patient was sent to the surgery for the resection of the involved colon segments.
DISCUSSION
Intestinal stricture which is an ongoing dynamic pathologic process includes fibrotic and antifibrotic components. There is a belief that intestinal fibrosis is preventive from the perforation of the effected bowel wall during the natural course of the disease in CD. So, the management of colonic stricture due to CD is a contraversial issue and has long been debated between gastroenterologists and surgeons (Strong et al., 2007; Lichtenstein et al., 2006; Vermeire et al., 2007; Van Assche et al., 2004; Hanauer et al., 2002) . Efficacy of biologics on stenosing forms of CD has not been established, so far. The main concern is that biologic agents might increase stricture rate and severity because of rapid mucosal healing induced fibrosis (Vermeire et al., 2007; Van Assche et al., 2004; Hanauer et al., 2002) . Others considered that biologics might decrease intestinal wall thickness rapidly and leads to colonic perforation.
Our patients'data in this study was obtained from the records of a tertial referral center and contains every stage of CD. Patients had most likely moderate or severe stage of the disease. To the best of our knowledge, for the first time, efficacy and safety of biologics was questioned in this study with 2 cases (numbers 3 and 9). We observed that biologic agents might be a safe therapy option in patients with colonic stenosing disease due to CD, provided patients should be carefully followed during the biologic therapies.
The incidence of colon cancer in patients with Crohn's colitis was reported to be 2 to 7%. Thus, colonoscopy with biopsies and brushing to evaluate for malignancy was highly recommended particularly when the disease was diagnosed at an older age, after longer disease duration, and with more extensive colon involvement (Lakatos et al., 2011; Yamazaki et al., 1991; Maykel et al., 2006) . In our study, we showed that pathologic examination of the stricture revealed no dysplasia or 
malignancy.
Fifty percent of the patients had elevated CRP (C reactive protein) or ESR (erythrocyte sedimentation rate) which reflected to active luminal disease. The number of 702 patients with CD is not a limitation in this study. So, 14 patients with colonic stricture due to CD in this study cannot be explained by the limited number of study population.
Conclusion
De novo colonic stricture due to CD is a rare condition and the distribution of the stricture varied from the rectum to ceacum. Biologics and tiopurines are reasonable alternatives to the surgery before giving a surgical desicion.
